A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice - PubMed (original) (raw)
Comparative Study
A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice
Rajeev I Desai et al. Pharmacol Biochem Behav. 2005 Aug.
Abstract
Efficacy in stimulating adenylyl cyclase (AC) has traditionally been used to distinguish dopamine D1-like receptor agonists from dopamine D2-like receptor agonists. However, there is a limited association between the effects of D1-like agonists in behavioral assays and their effectiveness at stimulating AC. Other second messenger actions might contribute to the behavioral effects of D1-like agonists, as there is evidence for a link to the hydrolysis of phosphoinositide (PI). The present study compared the locomotor stimulant effects of five D1-like receptor agonists having different efficacies in assays of AC and PI activity. All D1-like agonists produced long-lasting biphasic effects on locomotor activity. SKF 38393, the prototypical partial agonist (based on AC activity), produced limited changes in locomotor activity, whereas the partial agonists SKF 75670 and SKF 77434 produced locomotor stimulant effects that were similar to or greater than those of the full efficacy agonists SKF 82958 and SKF 81297. However, there did not appear to be a relationship between maximal behavioral effects and AC stimulation or PI hydrolysis. The results suggest a complex relationship between the behavioral effects of D1-like agonists and their intrinsic efficacies as measured by AC and /or PI stimulation. Although a limited number of compounds were examined, neither second messenger system alone appears to account fully for these behavioral effects. The current classification of D1-like agonists according to their intrinsic efficacies as defined by AC stimulation needs further scrutiny.
Similar articles
- Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Chausmer AL, Katz JL. Chausmer AL, et al. Psychopharmacology (Berl). 2002 Jan;159(2):145-53. doi: 10.1007/s002130100896. Epub 2001 Sep 22. Psychopharmacology (Berl). 2002. PMID: 11862342 - Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
Katz JL, Kopajtic TA, Myers KA, Mitkus RJ, Chider M. Katz JL, et al. J Pharmacol Exp Ther. 1999 Oct;291(1):265-79. J Pharmacol Exp Ther. 1999. PMID: 10490913 - Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
Platt DM, Rowlett JK, Spealman RD. Platt DM, et al. J Pharmacol Exp Ther. 2000 Jun;293(3):1017-26. J Pharmacol Exp Ther. 2000. PMID: 10869406 - Anti-atherosclerotic action of vascular D1 receptors.
Yasunari K, Kohno M, Kano H, Hanehira T, Minami M, Yoshikawa J. Yasunari K, et al. Clin Exp Pharmacol Physiol Suppl. 1999 Apr;26:S36-40. Clin Exp Pharmacol Physiol Suppl. 1999. PMID: 10386252 Review. - Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?
Lee SM, Yang Y, Mailman RB. Lee SM, et al. J Pharmacol Exp Ther. 2014 Oct;351(1):9-17. doi: 10.1124/jpet.114.214411. Epub 2014 Jul 22. J Pharmacol Exp Ther. 2014. PMID: 25052835 Free PMC article. Review.
Cited by
- Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains.
Thomsen M, Ralph RJ, Caine SB. Thomsen M, et al. Exp Clin Psychopharmacol. 2011 Oct;19(5):342-60. doi: 10.1037/a0024053. Exp Clin Psychopharmacol. 2011. PMID: 21843011 Free PMC article. - The Hypoactivity Associated with the Repeated Exposure to Atrazine Is Related to Decreases in the Specific Binding to D1-DA Receptors in the Striatum of Rats.
Márquez-Ramos JA, Hernández-Plata I, Díaz-Muñoz M, Rodríguez VM. Márquez-Ramos JA, et al. J Toxicol. 2017;2017:2169212. doi: 10.1155/2017/2169212. Epub 2017 Dec 6. J Toxicol. 2017. PMID: 29362563 Free PMC article. - Cognition and mood-related behaviors in L3mbtl1 null mutant mice.
Shen EY, Jiang Y, Mao W, Futai K, Hock H, Akbarian S. Shen EY, et al. PLoS One. 2015 Apr 7;10(4):e0121252. doi: 10.1371/journal.pone.0121252. eCollection 2015. PLoS One. 2015. PMID: 25849281 Free PMC article. - Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice.
Miller JS, Tallarida RJ, Unterwald EM. Miller JS, et al. Brain Res Bull. 2010 May 31;82(3-4):184-7. doi: 10.1016/j.brainresbull.2010.03.005. Epub 2010 Mar 25. Brain Res Bull. 2010. PMID: 20347018 Free PMC article. - The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist.
Natesan S, Reckless GE, Barlow KB, Odontiadis J, Nobrega JN, Baker GB, George SR, Mamo D, Kapur S. Natesan S, et al. Psychopharmacology (Berl). 2008 Aug;199(2):275-89. doi: 10.1007/s00213-008-1172-1. Epub 2008 Jun 3. Psychopharmacology (Berl). 2008. PMID: 18521575
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous